1. Home
  2. KLXE vs SPRO Comparison

KLXE vs SPRO Comparison

Compare KLXE & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • SPRO
  • Stock Information
  • Founded
  • KLXE 2018
  • SPRO 2013
  • Country
  • KLXE United States
  • SPRO United States
  • Employees
  • KLXE N/A
  • SPRO N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • SPRO Health Care
  • Exchange
  • KLXE Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • KLXE 35.8M
  • SPRO 33.0M
  • IPO Year
  • KLXE N/A
  • SPRO 2017
  • Fundamental
  • Price
  • KLXE $2.23
  • SPRO $0.65
  • Analyst Decision
  • KLXE Hold
  • SPRO Buy
  • Analyst Count
  • KLXE 1
  • SPRO 4
  • Target Price
  • KLXE $4.50
  • SPRO $5.00
  • AVG Volume (30 Days)
  • KLXE 173.4K
  • SPRO 96.2K
  • Earning Date
  • KLXE 05-08-2025
  • SPRO 05-13-2025
  • Dividend Yield
  • KLXE N/A
  • SPRO N/A
  • EPS Growth
  • KLXE N/A
  • SPRO N/A
  • EPS
  • KLXE N/A
  • SPRO N/A
  • Revenue
  • KLXE $688,600,000.00
  • SPRO $44,584,000.00
  • Revenue This Year
  • KLXE $0.22
  • SPRO N/A
  • Revenue Next Year
  • KLXE $4.89
  • SPRO N/A
  • P/E Ratio
  • KLXE N/A
  • SPRO N/A
  • Revenue Growth
  • KLXE N/A
  • SPRO N/A
  • 52 Week Low
  • KLXE $1.51
  • SPRO $0.51
  • 52 Week High
  • KLXE $7.66
  • SPRO $1.72
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 49.10
  • SPRO 47.70
  • Support Level
  • KLXE $1.80
  • SPRO $0.57
  • Resistance Level
  • KLXE $2.42
  • SPRO $0.70
  • Average True Range (ATR)
  • KLXE 0.24
  • SPRO 0.05
  • MACD
  • KLXE 0.09
  • SPRO 0.00
  • Stochastic Oscillator
  • KLXE 68.55
  • SPRO 44.75

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: